Lawesson's reagent → HCID 22281560, compound
Reaction equation
[CH2:1]([N:3]1[C:12]2[C:11](=O)[NH:10][CH2:9][C:8]([C:14]3[CH:19]=[CH:18][C:17]([O:20][CH3:21])=[CH:16][CH:15]=3)=[N:7][C:6]=2[C:5]([CH3:22])=[N:4]1)[CH3:2].COC1C=CC(P2(SP(C3C=CC(OC)=CC=3)(=S)S2)=[S:32])=CC=1>C1(C)C=CC=CC=1>[CH2:1]([N:3]1[C:12]2[C:11](=[S:32])[NH:10][CH2:9][C:8]([C:14]3[CH:19]=[CH:18][C:17]([O:20][CH3:21])=[CH:16][CH:15]=3)=[N:7][C:6]=2[C:5]([CH3:22])=[N:4]1)[CH3:2]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
(R1=methyl; R2=ethyl; R3=4-methoxyphenyl) 2.2 g (7.4 mmol) of 1-ethyl-5-(4-methoxyphenyl)-3-methyl-6,7-dihydro-1H-pyrazolo[4,3-e][1,4]diazepin-8-one are refluxed in toluene with 6 g (14.8 mmol) of Lawesson's reagent to give 2 g (87%) of an expected compound of type E (see Scheme 1).
Sources & evidence
- ORD record
- ord-c407af1f9d1546a5962deff32a216a50
- Source dataset
- uspto-grants-2007_06
- Patent number
- US07232816B2
Reaction notes
Loading…